Useful Links
Adult BNF Paediatric BNFBNF Apps (iOS and Android)
Further Medicines Management Resources
Antimicrobial guidelines
MHRA: Drug Safety Update (Sep 2019) Montelukast (Singulair): reminder of the risk of neuropsychiatric reactions
MHRA: Drug Safety Update (Sep 2019) Elmiron (pentosan polysulfate sodium): rare risk of pigmentary maculopathy
MHRA: Drug Safety Update (Sep 2019) Fingolimod (Gilenya▼): increased risk of congenital malformations; new contraindication during pregnancy and in women of childbearing potential not using effective contraception
MHRA: Drug Safety Update (Aug 2019) Hormone replacement therapy (HRT): further information on the known increased risk of breast cancer with HRT and its persistence after stopping
MHRA: Drug Safety Update (Aug 2019) Carfilzomib (Kyprolis▼): reminder of risk of potentially fatal cardiac events
MHRA: Drug Safety Update (Aug 2019) Naltrexone/bupropion (Mysimba▼): risk of adverse reactions that could affect ability to drive
